GOLDMAN SACHS GROUP INC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is and the CUSIP is 03209T208. A total of 39 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$3,01112,9210.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CVA Family Office, LLC 73,567$16,5670.00%
Cypress Capital Management LLC (WY) 9,266$2,0870.00%
StoneX Group Inc. 20,109$50.00%
Western Wealth Management, LLC 24,852$5,5970.00%
Delta Financial Group, Inc. 10,700$20.00%
COURIER CAPITAL LLC 38,326$8,6310.00%
Advisory Resource Group 10,000$2,2520.00%
BANK OF AMERICA CORP /DE/ 1,429$3220.00%
PNC FINANCIAL SERVICES GROUP, INC. 14$40.00%
JANICZEK WEALTH MANAGEMENT, LLC 1,115$3460.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders